Europe — EMA
Oncaspar (Pegaspargase)
Pegaspargase, the active ingredient in Oncaspar, is a antineoplastic agent presented as a sterile powder for intravenous infusion use.
Request sourcing
What is Pegaspargase?
Pegaspargase, the active ingredient in Oncaspar, is a antineoplastic agent presented as a sterile powder for intravenous infusion use. It is employed in the treatment of acute lymphoblastic leukemia, particularly in pediatric and young adult patients. GNH USA supplies Oncaspar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.
GNH USA supplies Oncaspar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.
What is Pegaspargase used for?
Oncaspar and ... .... .... ... .... ... .... … .... … … … … … … ... … ... … ...
